Research Paper Volume 11, Issue 12 pp 4075—4089
TGF-β1 enhances FOXO3 expression in human synovial fibroblasts by inhibiting miR-92a through AMPK and p38 pathways
Figure 6. The TGF-β1 and FOXO3 expression in OA patients. (A, B) Expression levels of TGF-β1 and FOXO3 in paired normal and OA tissues retrieved from the GEO dataset records (GDS5403). (C) Correlation between TGF-β1 and FOXO3 expression levels in OA specimens retrieved from the GEO dataset.